Status:
NOT_YET_RECRUITING
Clinical Feasibility of Mobile App-Based Self-Management for Breast Cancer-Related Lymphedema
Lead Sponsor:
Samsung Medical Center
Conditions:
Breast Cancer Related Lymphedema
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
The study evaluates a newly developed service that provides personalized self-management guidance based on evidence-based arm circumference measurements and resulting volume changes. The research aims...
Eligibility Criteria
Inclusion
- Between 18 and 70 years of age
- Diagnosed with breast cancer-related unilateral upper limb lymphedema
- Possessing an Android or iOS smartphone
- Voluntarily deciding to participate and providing written consent after receiving a detailed explanation of this study
Exclusion
- Diagnosed with malignant lymphedema due to metastasis or recurrence
- Having severe comorbidities (underlying diseases, neuromusculoskeletal disorders, cognitive, mental, or visual impairments, etc.) that make it difficult to use the application and participate in exercise interventions
- Discontinuation Criteria:
- Development of serious complications or cancer metastasis/recurrence during the study period
- Occurrence of a serious illness unrelated to study participation
- Failure to follow the instructions of the study physician
- Voluntary withdrawal from the study or development of circumstances preventing participation
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT06922513
Start Date
April 1 2025
End Date
December 1 2025
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, Republic of Korea, South Korea, 06351